Prolonged QT Interval in SARS-CoV-2 Infection: Prevalence and Prognosis
Background: The prognostic value of a prolonged QT interval in SARS-Cov2 infection is not well known. Objective: To determine whether the presence of a prolonged QT on admission is an independent factor for mortality in SARS-Cov2 hospitalized patients. Methods: Single-center cohort of 623 consecutiv...
Main Authors: | Núria Farré, Diana Mojón, Marc Llagostera, Laia C. Belarte-Tornero, Alicia Calvo-Fernández, Ermengol Vallés, Alejandro Negrete, Marcos García-Guimaraes, Yolanda Bartolomé, Camino Fernández, Ana B. García-Duran, Jaume Marrugat, Beatriz Vaquerizo |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2020-08-01
|
Series: | Journal of Clinical Medicine |
Subjects: | |
Online Access: | https://www.mdpi.com/2077-0383/9/9/2712 |
Similar Items
-
Managing QT prolongation in the Era of Coronavirus Disease 2019 (COVID-19)
by: sidhi laksono purwowiyoto
Published: (2020-05-01) -
HCQ induced QT prolongation- Primum non nocere
by: A.J. Mahendran, et al.
Published: (2020-09-01) -
Hydroxychloroquine and azithromycin use in COVID-19 era and cardiovascular concerns: Current perspective
by: Aditya Kapoor, et al.
Published: (2021-01-01) -
Mitigating arrhythmia risk in Hydroxychloroquine and Azithromycin treated COVID-19 patients using arrhythmia risk management plan
by: Kazimieras Maneikis, et al.
Published: (2021-02-01) -
Proarrhythmia assessment in treatment with hydroxychloroquine and azithromycin hospitalized elderly COVID-19 patients - our experience
by: Raffaele Costa, et al.
Published: (2021-06-01)